IRIS
Ceribelli, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.871
AS - Asia 3.217
EU - Europa 1.315
AF - Africa 703
SA - Sud America 600
Continente sconosciuto - Info sul continente non disponibili 83
OC - Oceania 7
Totale 10.796
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.755
SG - Singapore 1.889
CN - Cina 631
SC - Seychelles 610
BR - Brasile 500
IT - Italia 386
VN - Vietnam 293
FI - Finlandia 203
IE - Irlanda 144
DE - Germania 122
IN - India 90
HK - Hong Kong 89
FR - Francia 88
GB - Regno Unito 87
NL - Olanda 66
CA - Canada 54
AR - Argentina 41
MX - Messico 33
SE - Svezia 30
BD - Bangladesh 29
NG - Nigeria 29
RU - Federazione Russa 28
ZA - Sudafrica 24
IQ - Iraq 23
PL - Polonia 23
MK - Macedonia 20
TR - Turchia 20
ES - Italia 19
JP - Giappone 19
PK - Pakistan 19
EC - Ecuador 18
CZ - Repubblica Ceca 15
ID - Indonesia 14
PH - Filippine 14
AE - Emirati Arabi Uniti 13
MA - Marocco 11
BE - Belgio 10
CH - Svizzera 10
CO - Colombia 10
SA - Arabia Saudita 10
UA - Ucraina 10
CL - Cile 9
GR - Grecia 8
IL - Israele 8
PE - Perù 8
TN - Tunisia 8
UZ - Uzbekistan 8
AT - Austria 7
JM - Giamaica 7
JO - Giordania 7
AU - Australia 6
KR - Corea 6
MY - Malesia 6
VE - Venezuela 6
EG - Egitto 5
LB - Libano 5
NP - Nepal 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
DK - Danimarca 4
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
NO - Norvegia 4
PY - Paraguay 4
RO - Romania 4
AL - Albania 3
KE - Kenya 3
LT - Lituania 3
PT - Portogallo 3
SN - Senegal 3
AO - Angola 2
EE - Estonia 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
ML - Mali 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
Totale 10.701
Salva come PNG Salva come JPEG
Città #
Singapore 801
Chandler 606
Ashburn 573
San Jose 457
Dallas 382
The Dalles 297
Shanghai 232
Helsinki 203
New York 190
Council Bluffs 182
Boardman 169
Beijing 166
Dublin 142
Wilmington 137
Los Angeles 127
Ho Chi Minh City 116
Milan 113
Hong Kong 79
Hanoi 67
Santa Clara 64
Paris 59
San Mateo 54
Amsterdam 45
São Paulo 39
London 36
Buffalo 35
Rome 35
Ann Arbor 34
Falkenstein 31
Princeton 28
Benin City 27
Phoenix 27
Pune 27
Lawrence 26
Naples 26
Leawood 23
Columbus 21
Belo Horizonte 20
Brooklyn 20
Chicago 19
Warsaw 18
Chennai 17
Seattle 17
Montreal 16
Stockholm 16
Woodbridge 16
Boston 15
Frankfurt am Main 15
Rio de Janeiro 15
Mexico City 14
Orem 14
San Francisco 14
Da Nang 13
Fairfield 13
Assago 12
Tokyo 12
Toronto 12
Brno 11
Dhaka 11
Haiphong 11
Johannesburg 11
Brasília 10
Brussels 10
Houston 10
Baghdad 9
Charlotte 9
Munich 9
Skopje 9
Curitiba 8
Hangzhou 8
Philadelphia 8
Sassari 8
Aurora 7
Dubai 7
Figino 7
Hillsboro 7
Hyderabad 7
Miami 7
Pasadena 7
Quito 7
San Diego 7
Tashkent 7
Trieste 7
Turin 7
Amman 6
Atlanta 6
Fortaleza 6
Hải Dương 6
Istanbul 6
Jakarta 6
Kingston 6
Lima 6
Osasco 6
Porto Alegre 6
Thái Bình 6
Zurich 6
Bitola 5
Cape Town 5
Caxias do Sul 5
Guarulhos 5
Totale 6.302
Salva come PNG Salva come JPEG
Nome #
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 700
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 225
Acute phase reactions after zoledronic acid infusion: protective role of 25-OH vitamin D and previous oral bisphosphonate therapy 158
UTILIZZO DELLA MEPACRINA COME TERAPIA DELLE MANIFESTAZIONI CUTANEE NELLE CONNETTIVITI 146
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 145
Personalized medicine in rheumatology : the paradigm of serum autoantibodies 131
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy 128
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population 128
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 123
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 120
Lessons learned from twins in autoimmune and chronic inflammatory diseases 120
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis : a Critical Review 118
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review 116
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years 114
A case of psoriatic arthritis triggered by SARS-CoV-2 infection 110
Additional organs involved in antiphospholipid syndrome : eye, ear-nose-throat, lung, gastroenteric system, endocrine glands 110
Safety issues and concerns of new immunomodulators in rheumatology 110
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 107
Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis 105
Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation : the case of zoledronic acid-induced acute phase reaction 104
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies 103
Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression 101
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease 98
Effects of type II collagen epitope carbamylation and citrullination in HLA-DR4+ monozygotic twins discordant for rheumatoid arthritis 93
Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies 92
Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis 91
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 91
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 91
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma 90
Epigenetic Methods and Twin Studies 89
PFAPA syndrome and Behçet’s disease : a comparison of two medical entities based on the clinical interviews performed by three different specialists 88
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 87
Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement 87
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 86
Disease knowledge index and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 85
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS) 84
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 84
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 83
Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis 80
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals 78
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 78
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 78
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 77
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies 77
Humoral Response Against LL-37 in Psoriatic Disease: Comment on the Article by Yuan et al 76
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis 76
MicroRNAs in rheumatoid arthritis 75
AUTOANTIBODY TO RNA-PROTEIN COMPLEX DETECTED BY QUANTITATIVE PCR 75
Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis 73
A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis 72
Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways 72
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis 72
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 71
Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies 71
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits 70
Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy 70
Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender 69
Seronegative reactive spondyloarthritis and the skin 69
Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement 68
Psoriatic arthritis induced by anti-PD1 and treated with apremilast: a case report and review of the literature 68
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 68
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine 68
Cancer in connective tissue disease 67
MicroRNAs and autoimmunity 67
The Th17 axis in psoriatic disease : pathogenetic and therapeutic implications 67
The autoimmune landscape of Porto-sinusoidal vascular disorder: What the rheumatologist needs to know 66
Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis 66
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 66
Clinical Significance of Antinucleolar Antibodies: Biomarkers for Autoimmune Diseases, Malignancies, and others 66
Medical cannabis and cannabinoids in rheumatology: where are we now? 63
Unusual association between pure red cell aplasia and primary Sjögren's syndrome: a case report 63
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options 62
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals 62
Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay 61
Elastic properties of the ascending aorta in patients with rheumatoid arthritis 60
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies 60
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies 58
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 58
The interplay of epigenetics and epidemiology in autoimmune diseases: time for geoepigenetics 58
Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 58
MicroRNA-146a in autoimmunity and innate immune responses 58
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD) 58
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 57
PREVALENZA DI AUTOANTICORPI ANTI-KU NELLE MALATTIE AUTOIMMUNI SISTEMICHE E CARATTERISTICHE CLINICO-SIEROLOGICHE ASSOCIATE 57
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 56
Cardiological features in idiopathic inflammatory myopathies 56
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 56
Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study 55
Differential reactivity to IMPDH2 by anti-rods/rings autoantibodies and unresponsiveness to pegylated interferon-alpha/ribavirin therapy in US and Italian HCV patients 55
Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis 55
Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset 55
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus 54
The geoepidemiology of autoimmune liver disease 54
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis 53
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 53
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases 53
Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining 53
Neuropsychiatric aid in children born to patients with rheumatic diseases 53
Systemic rheumatic diseases: From biological agents to small molecules 52
Lupus T cells switched on by DNA hypomethylation via microRNA? 52
Totale 8.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022139 0 2 2 33 2 1 4 18 12 16 29 20
2022/20231.483 77 103 122 191 129 142 5 180 254 132 128 20
2023/20241.167 127 77 257 92 48 181 77 32 20 60 64 132
2024/20252.428 38 37 636 57 83 227 144 131 293 400 207 175
2025/20264.814 792 265 412 341 191 247 1.230 227 204 264 320 321
2026/2027485 241 244 0 0 0 0 0 0 0 0 0 0
Totale 10.796